We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NC6 market cap is 3.61M. The company's latest EPS is AUD -0.0078 and P/E is -2.56.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 236k | 562k | 323k | 225k | 412k |
Operating Income | -2.05M | -1.24M | -929k | -1.57M | -1.17M |
Net Income | -2M | -1.24M | -931k | -1.57M | -1.35M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 1.28M | 1.02M | 3.38M | 1.91M | 633k |
Total Liabilities | 158k | 237k | 508k | 182k | 181k |
Total Equity | 1.12M | 785k | 2.87M | 1.73M | 452k |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -1.86M | -946k | -935k | -1.38M | -1.01M |
Investing | -37k | -1,000 | -272k | -5k | N/A |
Financing | 42k | 663k | 3.38M | -33k | -27k |
Market Cap | 3.61M |
Price to Earnings Ratio | -2.56 |
Price to Sales Ratio | 8.33 |
Price to Cash Ratio | 6.25 |
Price to Book Ratio | 7.61 |
Dividend Yield | - |
Shares Outstanding | 172.01M |
Average Volume (1 week) | 125.52k |
Average Volume (1 Month) | 85.76k |
52 Week Change | -61.82% |
52 Week High | 0.06 |
52 Week Low | 0.016 |
Spread (Intraday) | 0 (8.7%) |
Company Name | Nanollose Limited |
Address |
suite 5 perth, western australia 6009 |
Website | https://www.nanollose.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions